START - Midwest Cancer Research Center — Grand Rapids, Michigan

START - Midwest Cancer Research Center is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

START - Midwest Cancer Research Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.

Sponsors: Iambic Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START - Midwest Cancer Research Center?

START - Midwest Cancer Research Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START - Midwest Cancer Research Center conducted?

START - Midwest Cancer Research Center has 1 clinical trials on record, with 1 currently active. Their work covers HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.

Is START - Midwest Cancer Research Center accredited by Crixeo Health?

START - Midwest Cancer Research Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START - Midwest Cancer Research Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.